Prognostic Value of MRI Assessment of Residual Peritumoral Edema in Breast Cancer Treated With Neoadjuvant Chemotherapy
Journal of Magnetic Resonance Imaging · 2025
DOI: 10.1002/jmri.29456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Hideo Shigematsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging, Neoadjuvant Therapy, Edema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: JSPS KAKENHI.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Peritumoral edema (PE) identified on T2‐weighted breast MRI is a factor for poor prognosis in breast cancer.
Purpose
To assess the prognostic value of residual PE (rPE) in patients with PE positive breast cancer prior to neoadjuvant chemotherapy (NACT) who subsequently underwent curative surgery. Study Type Retrospective. Population In total, 128 patients with nonmetastatic invasive breast cancer who underwent breast MRI before and after NACT. Field Strength/Sequence Axial precontrast 2D fast spin echo T2W fat‐suppressed sequence. Axial dynamic 3D gradient echo T1W fat‐suppressed sequence. Assessment PE was diagnosed when a signal intensity as high as water was detected surrounding the tumor on a T2‐weighted breast MRI. PE was qualitatively evaluated by three readers with more than 20 years of experience in interpreting breast field imaging findings. Residual cancer burden (RCB) were assessed post‐NACT. Recurrence‐free survival (RFS) and overall survival (OS) were evaluated as the endpoints of this study. Statistical Tests Chi‐square test; Kaplan–Meier method, log‐rank test, and Cox proportional hazard model. A P ‐value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
- Department of Radiology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
- Department of Pathology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
ORCID-Profile: Hideo Shigematsu
Förderung
- JSPS KAKENHI
Zitieren
APA
Shigematsu, H., Fujimoto, M., Kobayashi, Y., Yasui, D., Komoto, D., Matsuura, N., Kuraoka, K., & Yoshiyama, T. (2025). Prognostic Value of MRI Assessment of Residual Peritumoral Edema in Breast Cancer Treated With Neoadjuvant Chemotherapy. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29456
Vancouver
Shigematsu H, Fujimoto M, Kobayashi Y, Yasui D, Komoto D, Matsuura N, et al. Prognostic Value of MRI Assessment of Residual Peritumoral Edema in Breast Cancer Treated With Neoadjuvant Chemotherapy. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29456
BibTeX
@article{Shigematsu2025,
author = {Shigematsu, Hideo and Fujimoto, Mutsumi and Kobayashi, Yoshie and Yasui, Daisuke and Komoto, Daisuke and Matsuura, Noriaki and Kuraoka, Kazuya and Yoshiyama, Tomoyuki},
title = {Prognostic Value of MRI Assessment of Residual Peritumoral Edema in Breast Cancer Treated With Neoadjuvant Chemotherapy},
journal = {Journal of Magnetic Resonance Imaging},
year = {2025},
doi = {10.1002/jmri.29456}
}
EUVIMED